Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: April 2014

$824K Grant Awarded to Rutgers Cancer Institute Scientist to Develop Behavioral Interventions; Exploring Mobile App

New Brunswick, NJ, April 29, 2014 — While advances in cancer treatments have led to an increase in the number of childhood cancer survivors in the United States, this population faces significant health risks including early cardiovascular disease.

To address this concern, Katie Devine, PhD, a behavioral scientist at Rutgers Cancer Institute of New Jersey, will explore how a cancer-specific mobile application targeting physical activity might help this population.  Dr. Devine recently was awarded an $824,000 Career Development Grant from the National Cancer Institute which will support this work. Continue reading

Montclair State University to Host Sokol Science Lecture May 1

Montclair, NJ, April 28, 2014 — Montclair State University will host the Spring 2014 Margaret and Herman Sokol Science Lecture on Thursday May 1, 2014 at 8:00 p.m. in the University Hall Conference Center.

Eric D. Green, M.D., Ph.D., Director of the National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), will speak on “Human Genomics a Decade after the Human Genome Project: Opportunities and Challenges.”

The event is free but registration is required.  To register, click here.

New Brunswick, NJ, April 28, 2014 — Mary Jo Layton reports in The Record that a Rutgers University infectious disease expert will lead a $26 million five-year research project aimed at developing new antibiotics to tackle deadly bacteria that have become resistant to treatments, officials announced Friday.

David Perlin, executive director of the Public Health Research Institute at Rutgers New Jersey Medical School, will oversee the project, which will include scientists from Rutgers and other institutions to jump-start research that’s lagging behind other drug development.

More than 2 million people are sickened every year in the United States with antibiotic-resistant infections, resulting in at least 23,000 deaths annually, according to the federal Centers for Disease Control and Prevention. Continue reading

Applications Now Being Accepted for 2014 Governor’s STEM Scholars Program

Chatham, NJ, April 23, 2014 — The Governor’s STEM Scholars program is now accepting applications for 2014.This program is a public-private initiative of the Research & Development Council of New Jersey, the Governor’s Office, the New Jersey Department of Education, and the Secretary of Higher Education.

The program provides the students — from tenth grade through Ph.D. — with a unique and comprehensive introduction to sciences, technology, engineering and mathematics (STEM) in the state.  

The students will learn about STEM through a series of conferences that take place around the New Jersey, along with field trips to research labs and Q&As with STEM professionals.   Continue reading

Government and Industry Leaders Herald Launch of New Jersey Innovation Institute, An NJIT Corporation

Newark, NJ, April 22, 2014 — Government and industry leaders today gathered at the New Jersey Institute of Technology (NJIT) to join NJIT President Joel S. Bloom for the launch of the New Jersey Innovation Institute (NJII), an NJIT corporation that provides a new model for business innovation through the leveraging of industry, government, and higher education assets and investment.

U.S. Senator Cory Booker, Panasonic Corp. of North America Chairman and CEO Joe Taylor, New Jersey Lieutenant Governor Kim Guadagno, New Jersey Secretary of Higher Education Rochelle Hendricks, and New Jersey State Senator Raymond Lesniak attended the NJII event and discussed the importance of the venture as well as its potential to facilitate economic development through the marriage of industry-driven agendas and NJIT’s intellectual and technological assets.

Bloom noted NJIT’s long history of partnership with private industry, saying, “Economic development…is in NJIT’s blood and is expressly stated as part of our mission.” Continue reading

Rutgers’ Aresty Symposium to Showcase Undergrad Student Research on April 25

New Brunswick, NJ, April 22, 2014 — Carl Blesch and Robin Lally report that, for the past decade, the benefits of a public research university have been exhibited annually at Rutgers’ Aresty Undergraduate Research Symposium, where more than 2,000 students have had the opportunity to showcase the results of their work in areas that span the humanities, social sciences, technology, and life and physical sciences.

This year’s 10th anniversary research symposium, which takes place from 10:30 a.m. to 2:00 p.m. Friday, April 25, at the Livingston Student Center, will feature the research of more than 500 students.

To conduct their own independent study, these undergraduates have taken advantage of mentoring provided by Rutgers faculty whose research bridges diverse fields. Continue reading

NJ Big Data Alliance to Host Inaugural Symposium, ‘Partnership in Big Data,’ April 23 at Rutgers

New Brunswick, NJ, April 21, 2014 — The New Jersey Big Data Alliance (NJBDA) will launch officially at its inaugural symposium, entitled “Partnerships in Big Data:  Pathways to Transformative Innovation in New Jersey,” on Wednesday, April 23 from 8:15 a.m. to 5:00 p.m. at Rutgers’ Livingston Hall at 88 Joyce Kilmer Avenue in Piscataway.

The proliferation of data sources and the resultant deluge of digital data is significantly impacting all sectors of industry, academia and society.  Challenges associated with the collection, management and analysis of extremely large data sets permeate many industry sectors in New Jersey including the financial, biopharmaceutical, insurance and energy sectors. Continue reading

Seats Added to Help New Jersey’s Veterans Find New Careers at Inaugural Veteran and Transitioning Military Re-Careering Seminar

Somerville, NJ, April 17, 2014 — On April 29, the MedTech and BioTech Veterans Program (www.mvpvets.com ) will host its inaugural re-careering event for transitioning military and veterans in New Jersey. 

Military personnel in transition from service and honorably discharged veterans are invited to apply for the opportunity to participate in this free one day seminar that will include active one-on-one mentoring, industry specific training, eLearning enrollment, and personal engagement with hiring managers seeking to employ program participants. 

Enrollment has been increased to 30 participants in order to help veterans in New Jersey and the surrounding area find new careers in areas such fields as project management, supply chain, quality control, human resources, and many others. Continue reading

IMS Report Shows U.S. Spending on Medicines Up; Record Number of Transformative Drugs Launched

Parsippany, NJ, April 16, 2014 — Total spending on U.S. medicines increased 1.0 percent on a real per capita basis in 2013, while the use of healthcare services overall rose for the first time in three years, according to a new report issued yesterday by the IMS Institute for Healthcare Informatics.

The study — Medicine Use and Shifting Costs of Healthcare: A Review of the Use of Medicines in the United States in 2013 — found that total dollars spent on medications in the U.S. reached $329.2 billion last year, up 3.2 percent on a nominal basis and a rebound from the 1.0 percent decline in 2012.

 Primary drivers include the reduced impact of patent expiries, price increases, higher spending on innovative new medicines, and greater use by patients of the healthcare system.  

Patent expiries in 2013 contributed $19 billion to lower medicine spending, compared with $29 billion the previous year.   Continue reading

PhRMA CEO’s NJTV News Interview: Biopharma Is a ‘Very Vibrant’ Part of NJ Economy

Montclair, NJ, April 14, 2014 — In an interview on “NJTV News with Mike Schneider” broadcast on April 11, Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani said New Jersey is the “medicine chest of America” with 70,000 direct employees in the biopharmaceutical industry. 

The rollout of the Affordable Care Act has been contentious throughout the country, particularly in the business community.  Castellani told NJTV News Managing Editor Mike Schneider that the new health care law has changed the way care is provided and has lowered premiums, but raised out-of-pocket expenses.

“There is a real political imperative to have a low premium,” Castellani explained.  “But to have a low premium, there are very large out-of-pocket expenses and first dollar expenses for patients. And so what we’re gonna have to watch very carefully is how that affects patients, particularly those with chronic diseases, and their ability to continue to afford their medicines.” Continue reading